JP1685483S - - Google Patents

Info

Publication number
JP1685483S
JP1685483S JPD2020-18329F JP2020018329F JP1685483S JP 1685483 S JP1685483 S JP 1685483S JP 2020018329 F JP2020018329 F JP 2020018329F JP 1685483 S JP1685483 S JP 1685483S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-18329F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-18329F priority Critical patent/JP1685483S/ja
Priority to US29/769,596 priority patent/USD971785S1/en
Application granted granted Critical
Publication of JP1685483S publication Critical patent/JP1685483S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-18329F 2020-08-31 2020-08-31 Active JP1685483S (show.php)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2020-18329F JP1685483S (show.php) 2020-08-31 2020-08-31
US29/769,596 USD971785S1 (en) 2020-08-31 2021-02-05 Electric car body with information display

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-18329F JP1685483S (show.php) 2020-08-31 2020-08-31

Publications (1)

Publication Number Publication Date
JP1685483S true JP1685483S (show.php) 2021-05-17

Family

ID=75900540

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-18329F Active JP1685483S (show.php) 2020-08-31 2020-08-31

Country Status (2)

Country Link
US (1) USD971785S1 (show.php)
JP (1) JP1685483S (show.php)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1011962S1 (en) * 2021-07-07 2024-01-23 Pininfarina S.P.A. Car

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD419485S (en) * 1997-03-24 2000-01-25 Trans2 Corporation Miniature passenger vehicle
USD639208S1 (en) * 2010-05-27 2011-06-07 Suzhou Eagle Electric Vehicle Manufacturing Co., Ltd. Electric vehicle
USD671452S1 (en) * 2011-03-15 2012-11-27 Afypaida (Asociacion Para el Fomento de Actividades de Automocion) Automobile
USD871258S1 (en) * 2013-03-01 2019-12-31 Organic Transit, Inc. Hybrid pedal and electric powered vehicle
WO2016055873A1 (en) * 2014-10-08 2016-04-14 Interactive Fully Electrical Vehicles S.R.L. Electric car with pre-assembled modular structure
USD807786S1 (en) * 2016-03-16 2018-01-16 Daimler Ag Motor vehicle, toy, and/or replicas thereof
JP1591002S (show.php) * 2017-04-05 2018-11-12
USD856847S1 (en) * 2018-02-05 2019-08-20 Beijing Linkdata Technologies Co. Ltd. 4 wheeled bike
JP1627864S (ja) * 2018-07-31 2019-04-01 電動自動車
USD947070S1 (en) * 2019-07-08 2022-03-29 Hyperion Motors, Inc. Vehicle chassis
JP1685675S (show.php) * 2019-10-21 2021-05-24
USD945923S1 (en) * 2019-11-11 2022-03-15 Beijing Niu Information Technology Co., Ltd. Electric three-wheeled vehicle
JP1700225S (show.php) * 2021-04-02 2021-11-22

Also Published As

Publication number Publication date
USD971785S1 (en) 2022-12-06

Similar Documents

Publication Publication Date Title
BR102021007058A2 (show.php)
BR102020022030A2 (show.php)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134206A1 (es) Degradantes y usos de los mismos
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos